Source link : https://newshealth.biz/health-news/in-high-risk-b-cell-all-swapping-out-chemo-for-blinatumomab-improves-outcomes/
Replacing two high-dose chemotherapy courses with blinatumomab (Blincyto) significantly improved event-free survival (EFS) in pediatric patients with newly diagnosed high-risk B-cell acute lymphoblastic leukemia (ALL), an interim analysis from a phase III trial showed. The 4-year EFS rate was 83% for those treated with the bispecific T-cell engager versus 70.3% for those treated with chemotherapy […]
The post In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-15 20:39:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8